Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XBI vs. RYOIX: which is better?

Bottom line

XBI vs RYOIX: the short answer

XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and RYOIX (Biotechnology Fund) are quite different portfolios: only about 15% of their top holdings (by weight) are shared.

But XBI is far broader, holding 161 positions to 74 for RYOIX, so beyond the top names it adds exposure RYOIX doesn't have.

XBI is cheaper at 0.35% vs 1.38% — a difference of $103 a year per $10,000 invested.

Over five years, RYOIX returned +4.0% a year vs −2.7% for XBI.

Updated Nov 19, 2026

XBI vs RYOIX side by side

XBIRYOIX
TypeETFMutual fund
Fund familySPDR (State Street)Guggenheim
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%1.38%
Annual cost per $10k$35$138
10-yr cost on $10k (prospectus)$443$1,709
Max front loadNone—
12b-1 fee0%0%
1-yr return+35.8%+30.7%
5-yr return (annualized)−2.7%+4.0%
10-yr return (annualized)+5.8%+5.9%
Best quarter+44.4%+28.3%
Worst quarter−26.2%−22.5%
Net assets (fund)$10.7B$136.8M
Number of holdings16174
Portfolio turnover71%75%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXBIRYOIXDifference
2025+35.8%+30.7%+5.1%
2024+1.1%−0.7%+1.8%
2023+7.5%+6.1%+1.4%
2022−25.8%−13.1%−12.7%
2021−20.5%+1.8%−22.3%
2020+48.2%+22.1%+26.1%
2019+32.2%+25.0%+7.2%
2018−14.9%−9.0%−5.9%
2017+43.7%+29.7%+13.9%
2016−15.4%−19.5%+4.1%

Source: Fund prospectus bar charts

Holdings overlap

5 of XBI's top 25 holdings also appear in RYOIX's top 25.

Shared top holdings
HoldingXBIRYOIX
Moderna Inc1.41%2.15%
Revolution Medicines Inc1.20%2.48%
Cytokinetics Inc1.18%1.35%
Natera Inc1.16%2.12%
Roivant Sciences Ltd1.16%1.66%

Source: SEC Form N-PORT

XBI top 10

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Moderna Inc — 1.41%
  4. Twist Bioscience Corp — 1.41%
  5. Oruka Therapeutics Inc — 1.38%
  6. Kymera Therapeutics Inc — 1.36%
  7. Viking Therapeutics Inc — 1.30%
  8. Praxis Precision Medicines Inc — 1.29%
  9. Erasca Inc — 1.27%
  10. Revolution Medicines Inc — 1.20%

RYOIX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

FAQ

What is the difference between XBI and RYOIX?
XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and RYOIX (Biotechnology Fund) are quite different portfolios: only about 15% of their top holdings (by weight) are shared. But XBI is far broader, holding 161 positions to 74 for RYOIX, so beyond the top names it adds exposure RYOIX doesn't have.
Which is cheaper, XBI or RYOIX?
XBI has the lower expense ratio (0.35%).
Should I own both XBI and RYOIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.